Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Firm will continue test-marketing Elations Dietary Supplement drink despite Sept. 26 announcement it is no longer pursuing joint venture with Coca-Cola to market health and wellness beverages, snacks. P&G debuted Elations - a beverage targeting "joint flexibility and skeletal strength" and containing glucosamine, calcium and vitamin C - in "learning" markets in Cape Coral and Sarasota, Fla. earlier this year. The 8-oz. drink comes in Cranberry Apple Twist and Ruby Red Grapefruit Lift flavors, retailing for about $10 for an eight-pack, $35 for a 28-pack. The Elations brand originally was to be housed under the P&G/Coca-Cola joint venture announced in February (1"The Tan Sheet" March 5, In Brief)

You may also be interested in...

Functional Pringles?

Accelerated introduction of vitamin- and nutrient-fortified snacks and juice beverages may be on the horizon from joint venture recently formed by P&G and Coca-Cola. "Innovation and a substantial new product pipeline" will be P&G's primary forward-looking contributions to the yet-unnamed company, CFO Clayton Daley tells analysts during Merrill Lynch consumer product investor conference Feb. 27. P&G owns approximately 3,000 patents in the food/beverage area, including "substantial positions in calcium, iron, vitamin A and iodine fortification," as well as accompanying flavor-masking technology, Daley notes

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts